Toxic excipients in medications for neonates in Brazil

European Journal of Pediatrics

Volumn 173, Issue 7, 2014, Pages 935-945

  Souza, Alcidésio ^a,b   Santos, Djanilson ^b,c   Fonseca, Said ^b   Medeiros, Marina ^b   Batista, Lívia ^b   Turner, Mark ^d   Coelho, Helena ^b  

^a Brasilia Mother and Child Hospital   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c UNIVERSIDADE FEDERAL DO RECÔNCAVO DA BAHIA   (Brazil)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Drug; Harmful excipients; Neonate; Potentially harmful excipients

Indexed keywords

ACETIC ACID; ALCOHOL; AMINOPHYLLINE; BENZALKONIUM CHLORIDE; BENZOIC ACID; BENZYL ALCOHOL; CITRATE SODIUM; CITRIC ACID; DOMPERIDONE; ETHYLENEDIAMINE; EXCIPIENT; GLYCEROL; HYDROCHLORIC ACID; METHYL PARABEN; MICROCRYSTALLINE CELLULOSE; MULTIVITAMIN; PHENOL; POLYSORBATE 80; PROPYL PARABEN; PROPYLENE GLYCOL; RANITIDINE; RICINOMACROGOL; SACCHARIN SODIUM; SIMETHICONE; SODIUM CHLORIDE; SODIUM HYDROXIDE; STARCH; STEARIC ACID; UNINDEXED DRUG; WATER; DRUG;

ARTICLE; BRAZIL; DRUG EXPOSURE; DRUG FORMULATION; FEMALE; HOSPITAL ADMISSION; HOSPITALIZED INFANT; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INTENSIVE CARE; PREMATURITY; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; RISK FACTOR; CHEMISTRY; HOSPITALIZATION; STATISTICS AND NUMERICAL DATA; TOXICITY;

BRAZIL; DRUG PRESCRIPTIONS; EXCIPIENTS; FEMALE; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; MALE; PHARMACEUTICAL PREPARATIONS; RETROSPECTIVE STUDIES;

EID: 84903814874     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-014-2272-z     Document Type: Article

References (35)

1. Allegaert K, Langhendries JP, van den Anker J (2013) Do we need neonatal clinical pharmacologists? Eur J Pediatr 172(4):429-435. doi:10.1007/s00431-012- 1734-4
2. Allegaert K, Vanhaesebrouck S, Kulo A, Cosaert K, Verbesselt R, Debeer A, de Hoon J (2010) Prospective assessment of short-term propylene glycol tolerance in neonates. Arch Dis Child 95(12):1054-1058. doi:10.1136/adc.2010. 190330
3. ANVISA (2013) Bulário Eletrônico. http://www4.anvisa.gov.br/ BularioEletronico. Accessed 01 June 2013
4. Calafat AM, Weuve J, Ye X, Jia LT, Hu H, Ringer S, Huttner K, Hauser R (2009) Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Heal Perspect 117(4):639-644. doi:10.1289/ehp. 0800265
5. Carvalho CG, Ribeiro MR, Bonilha MM, Fernandes M Jr, Procianoy RS, Silveira RC (2012) Use of off-label and unlicensed drugs in the neonatal intensive care unit and its association with severity scores. J Pediatr (Rio J) 88(6):465-470. doi:10.2223/JPED.2231
6. Centralx (2013) Sistemas Inteligentes em Saúde. http://www.bulas.med.br. Accessed 01 June 2013
7. Coelho HL, Rey LC, Medeiros MS, Barbosa RA, Cruz Fonseca SG, Costa PQ (2013) A critical comparison between the World Health Organization list of essential medicines for children and the Brazilian list of essentialmedicines (Rename). J Pediatr (Rio J) 89(2):171-178. doi:10.1016/j.jped.2013.03.004
8. De Cock RF, Knibbe CA, Kulo A, de Hoon J, Verbesselt R, Danhof M, Allegaert K (2013) Developmental pharmacokinetics of propylene glycol in preterm and term neonates. Br J Clin Pharmacol 75(1): 162-171. doi:10.1111/j.1365-2125. 2012.04312.x
9. Dell'Aera M, Gasbarro AR, Padovano M, Laforgia N, Capodiferro D, Solarino B, Quaranta R, Dell'Erba AS (2007) Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm World Sci: PWS 29(4):361-367. doi:10.1007/s11096-006-9081-z (Pubitemid 47196657)
10. EMEA/536810/2008 (2010) Guideline on the investigation of medicinal products in the term and preterm neonate. EMEA. http://www.ema.europa.eu/docs/ en-GB/document-library/Scientific-guideline/2009/09/WC500003750.pdf. Accessed 01 February 2013
11. EMEA/CHMP/PEG/194810/2005 (2006) Reflection paper: formulations of choice for the paediatric population. EMEA. http://www.ema.europa.eu/docs/en-GB/ document-library/Scientific-guideline/2009/09/WC500003782.pdf. Accessed 01 February 2013
12. Fabiano V, Mameli C, Zuccotti GV (2011) Paediatric pharmacology: remember the excipients. Pharmacol Res: Off J Ital Pharmacol Soc 63(5):362-365. doi:10.1016/j.phrs.2011.01.006
13. Giacoia GP, Taylor-Zapata P, Zajicek A (2012) Drug studies in newborns: a therapeutic imperative. Clin Perinatol 39(1):11- 23. doi:10.1016/j.clp.2011.12. 016
14. Jacqz-Aigrain E (2011) Drug policy in Europe research and funding in neonates: current challenges, future perspectives, new opportunities. Early Hum Dev 87(Suppl 1):S27 - S30. doi:10.1016/j.earlhumdev.2011.01.007
15. Kalikstad B, Skjerdal A, Hansen TW (2010) Compatibility of drug infusions in the NICU. Arch Dis Child 95(9):745-748. doi:10.1136/adc.2009.174268
16. Kulo A, de Hoon JN, Allegaert K (2012) The propylene glycol research project to illustrate the feasibility and difficulties to study toxicokinetics in neonates. Int J Pharm 435(2):112-114. doi:10.1016/j.ijpharm.2012.05.014
17. Lass J, Naelapaa K, Shah U, Kaar R, Varendi H, Turner MA, Lutsar I (2012) Hospitalised neonates in Estonia commonly receive potentially harmful excipients. BMC Pediatr 12:136. doi:10.1186/1471-2431-12-136
18. Malcolm WF, Cotten CM (2012) Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates. Clin Perinatol 39(1):99-109. doi:10.1016/j.clp.2011.12.015
19. Nahata MC (2009) Safety of "inert" additives or excipients in paediatric-medicines. Arch Dis Child Fetal Neonatal Ed 94(6):F392-F393. doi:10.1136/adc.2009.160192
20. Nair B (2001) Final report on the safety assessment of benzyl alcohol, benzoic acid, and sodium benzoate. Int J Toxicol 20(Suppl 3):23-50
21. Nellis G, Metsvaht T, Lass J, Varendi H, Turner MA, Lutsar I (2013) European Study of Neonatal Excipient Exposure (ESNEE): preliminary results of the point prevalence survey. In: 14th Biannual Congress of the European Society for Developmental Perinatal and Pediatric Pharmacology (EDPPP), Salzburg, Austria, German Medicam Science GMS Publishing House, Düsseldorf. http://www.esdppp.org/site/wp-content/uploads/2013/06/ESDP%20ibook%20final%201. 1%20light.pdf. Accessed 04 December 2013
22. Neubert A, Lukas K, Leis T, Dormann H, Brune K, Rascher W (2010) Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis. Eur J Clin Pharmacol 66(1):87-95. doi:10.1007/s00228-009-0722-8
23. Pifferi G, Restani P (2003) The safety of pharmaceutical excipients. Farmaco 58(8):541-550 (Pubitemid 36870826)
24. Rowe RC, Sheskey PJ, Quinn ME (2009) Handbook of pharmaceutical excipients, 6th edn. Pharmaceutical Press, London
25. Salunke S, Brandys B, Giacoia G, Tuleu C (2013) The STEP (Safety and Toxicity of Excipients for Paediatrics) database: part 2 - the pilot version. Int J Pharm 457(1):310-322. doi:10.1016/j.ijpharm.2013.09.013
26. Shehab N, Lewis CL, Streetman DD, Donn SM (2009) Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. Pediatr Crit Care Med: J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc 10(2):256-259. doi: 10.1097/PCC.0b013e31819a383c
27. Tuleu C, Breitkreutz J (2013) Educational paper: formulation-related issues in pediatric clinical pharmacology. Eur J Pediatr 172(6):717-720. doi:10.1007/s00431-012-1872-8
28. Turner MA, Duncan J, Shah U, Metsvaht T, Varendi H, Nellis G, Lutsar I, Vaconsin P, Storme T, Rieutord A, Nunn AJ (2013) European study of neonatal exposure to excipients: an update. Int J Pharm 457(1):357-358. doi:10.1016/j.ijpharm.2013.08.078
29. Turner MA, Duncan JC, Shah U, Metsvaht T, Varendi H, Nellis G, Lutsar I, Yakkundi S, McElnay JC, Pandya H, Mulla H, Vaconsin P, Storme T, Rieutord A, Nunn AJ (2013) Risk assessment of neonatal excipient exposure: lessons from food safety and other areas. Adv Drug Deliv Rev. doi:10.1016/j.addr.2013.11.003
30. US/FDA (2011) FDA drug safety communication: serious health problems seen in premature babies given Kaletra (lopinavir/ritonavir) oral solution. http://www.fda.gov/Drugs/DrugSafety/ucm246002.htm. Accessed 05/12/2013
31. US/NLM (2013) Haz-Map®. U.S. National Library of Medicine. http://hazmap.nlm.nih.gov. Accessed 10 July 2013
32. US/NLM/SIS (2013) TOXNET. U.S. National Institutes of Health. http://toxnet.nlm.nih.gov/. 10 July 2013
33. van Riet-Nales DA, de Jager KE, Schobben AF, Egberts TC, Rademaker CM (2011) The availability and age-appropriateness of medicines authorized for children in the Netherlands. Br J Clin Pharmacol 72(3):465-473. doi:10.1111/j.1365-2125.2011.03982.x
34. Whittaker A, Currie AE, Turner MA, Field DJ, Mulla H, Pandya HC (2009) Toxic additives in medication for preterm infants. Arch Dis Child Fetal Neonatal Ed 94(4):F236-F240. doi:10.1136/adc.2008.146035
35. WHO (2010) Anatomical-therapeutical-chemical (atc) classification - index and guidelines. http://www.who.int/classifications/atcddd/en. Accessed 10 July 2013